SEC Company Response from MARIMED INC. (MRMD) (CIK 0001522767) (MRMD) — Apr 27, 2021
MARIMED INC. (MRMD) (CIK 0001522767)
Date: April 27, 2021 · CIK: 0001522767 · Accession: 0001493152-21-009819
AI Filing Summary & Sentiment
File numbers found in text: 333-255338
Show Raw Text
CORRESP
1
filename1.htm
MARIMED
INC.
10
Oceana Way
Norwood,
Massachusetts 02062
April
27, 2021
FILED
VIA EDGAR
United
States Securities and Exchange Commission
Division
of Corporation Finance
Office
of Technology
Washington,
DC 20549
Attn:
Mr. Mitchell Austin, Staff Attorney
Re:
MariMed
Inc. (the “Company”)
Registration
Statement on Form S-3, SEC File No. 333-255338
(the
“Registration Statement”)
Dear
Mr. Austin:
In
connection with the proposed public offering of Company securities under the above referenced Registration Statement, the Company hereby
requests, pursuant to Rule 461(a) under the Rules and Regulations promulgated under the Securities Act of 1933, as amended, that the
Registration Statement become effective at 4.00 p.m. Eastern Daylight Savings Time, on Wednesday, April 28, 2021, or as soon thereafter
as practicable.
With
respect to this request the Company acknowledges that:
●
Should
the Commission or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose
the Commission from taking any action with respect to the Registration Statement;
●
The
action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective
does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement;
and
●
The
Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission
or any person under the federal securities laws of the United States.
Very
truly yours,
MARIMED
INC.
By:
/s/
Jon R. Levine
Jon
R. Levine
Chief
Financial Officer